Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-20.73%
↓ 70% vs avg
Percentile
P46
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-12.18%
Historical baseline
PeriodValue
2024-20.73%
202311.96%
2022-19.71%
2021-36.49%
202053.87%
2019-74.32%
2018-16.26%
201767.05%
2016-22.77%
2015-64.40%